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In Western Australia, Neisseria meningitidis serogroup W 
clonal complex 11 became the predominant cause of inva-
sive meningococcal disease in 2016. We used core-genome 
analysis to show emergence of a penicillin-resistant clade 
that had the penA_253 allele. This new penicillin-resistant 
clade might affect treatment regimens for this disease.
Invasive meningococcal disease (IMD) is caused by a meningococcus, Neisseria meningitidis. The main mani-
festations of this disease are septicemia or meningitis. Me-
ningococcal strains can be classified into 12 serogroups 
phenotypically and into sequence types (STs) by multilocus 
sequence typing (1). Similar STs are grouped into the same 
clonal complex (cc). IMD is most commonly caused by 
isolates expressing a serogroup A, B, C, W, X, or Y poly-
saccharide capsule. Until recently, serogroup A was the ma-
jor cause of disease in Africa (2). Serogroups B, C, and Y 
continue to predominate in the United States, Europe, Asia, 
and Australia (3,4).
In Australia, after introduction of serogroup C conju-
gate vaccine in the national immunization program in 2003, 
incidence of serogroup C has decreased; serogroup B pre-
dominated during 2004–2015. However, during 2016, the 
prevalence of serogroup W disease increased because of N. 
meningitidis strains in the cc11 lineage (MenW:cc11) (5,6), 
which have also been reported worldwide. Although ex-
tensive core-genome analyses of these MenW:cc11 strains 
have been reported (7,8), antimicrobial drug susceptibility 
of these clinical isolates has not been generally reported.
Although penicillin has been used for control of IMD, 
clinical isolates relatively resistant to this drug have been 
reported worldwide. For meningococci, a penicillin MIC 
>2 mg/L is caused by plasmid-mediated β-lactamase 
production but is extremely rare (9). Conversely, isolates 
conferring intermediate resistance to penicillin (MIC 
0.12–0.25 mg/L) are uncommon but the frequency of these 
isolates varies geographically. The mechanism of relative 
resistance in these isolates involves expression of altered 
forms of 1 of 4 penicillin-binding proteins (PBPs) that are 
involved in peptidoglycan biosynthesis during bacterial 
growth and cell division (10).
Although treatment with penicillin is still effective 
against these penicillin-intermediate strains, low-dose 
treatment regimens may fail for cases involving penicillin-
resistant isolates (MIC >0.5 mg/L) (11). We report recent 
emergence and clonal expansion of a phylogenetically re-
lated cluster of penicillin-resistant MenW:cc11 isolates in 
Western Australia.
The Study
Western Australia is the largest state in Australia (land area 
1.02 million square miles). However, it has a population of 
only 2.5 million persons. In concordance with the national 
trend, there has been a shift in the predominant serogroup in 
Western Australia; MenW was responsible for most IMD 
cases in 2016. The first laboratory-confirmed MenW:cc11 
case in Western Australia was recorded in April 2013 and 
was the only MenW case for that year. Since that time, 
an additional 18 MenW:cc11 laboratory-confirmed cases 
have been reported, representing 11% (n = 2) of all IMD 
cases in 2014, 27% (n = 3) in 2015, and 67% (n = 13) in 
2016, a significant increase from 2014 through 2016 (p = 
0.0004, by Fisher exact test). Three deaths were caused by 
MenW:cc11 infection, 1 in 2015 and 2 in 2016.
The 19 MenW:cc11 strains isolated during January 1, 
2013–December 31, 2016, were assessed for susceptibil-
ity to penicillin, ciprofloxacin, ceftriaxone, and rifampin. 
We performed drug susceptibility testing by using the Etest 
(bioMérieux, Marcy l’Etoile, France). MIC results were in-
terpreted according to Clinical Laboratory Standard Insti-
tute (http://clsi.org) breakpoints. All isolates were suscepti-
ble to ciprofloxacin (MIC <0.03 mg/L), ceftriaxone (<0.12 
mg/L), and rifampin (<0.5 mg/L). However, variation in 
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penicillin susceptibility was observed: 8 were susceptible 
(<0.06 mg/L), 2 were less susceptible (0.12–0.25 mg/L), 
and 9 were resistant (>0.5 mg/L). All isolates less suscep-
tible to or resistant to penicillin were identified in 2016.
We further characterized isolates by using whole-ge-
nome sequencing with the Miseq Platform (Illumina, San 
Diego, CA, USA). Raw reads were assembled, auto-tagged, 
and curated by using the BIGSdb genomics platform on the 
PubMLST website (http://pubmlst.org/neisseria) (12). Four 
STs, all belonging to cc11, were identified: ST-11 (n = 11), 
ST-1287 (n = 2), ST-3298 (n = 1), and ST-12351 (n = 5). 
All isolates had the same PorA:FetA profile (P1.5,2:F1–1) 
as that identified in the MenW:cc11 collection responsible 
for outbreaks in South America and the United Kingdom 
(8). Furthermore, genomic sequences indicated the isolates 
from Western Australia were within the same United King-
dom–South America cluster as isolates from the eastern 
coast of Australia (13).
Phylogenetic analysis of the meningococcal core 
genome (14) identified 2 distinct clusters within the 
MenW:cc11 population of Western Australia (Figure 1). 
One isolate (ExNm672) was an outlier and could not be 
clustered. ExNm672 was isolated from a traveler from 
Asia who had recently arrived in Western Australia, which 
would likely explain the different genealogy of this strain. 
All isolates less susceptible to or resistant to penicillin 
were in cluster B. Geocoding analysis showed that the 10 
isolates in cluster B were obtained from 7 geographically 
well-separated regions in Western Australia. This obser-
vation suggests successful expansion of a new penicillin-
resistant clone in 2016.
For N. meningitidis, polymorphisms within the gene 
encoding PBP2, also known as penA, are associated with 
a reduced affinity, and thus a decrease in susceptibility, to 
penicillin. All isolates in cluster A had the penA_59 allele, 
and isolates in cluster B had the penA_253 allele. These 
alleles differ by 101 nt, and the encoded peptides differ 
at 25 aa positions. The different amino acid residues are 
located in the second half of the protein, which contains 
the transpeptidase domain for penicillin binding. Six of 
the amino acid mutations encoded by penA_253 (F504L, 
A510V, N512Y, I515V, H541N, and I566V) have been 
reported to be associated with decreased susceptibility to 
penicillin (15).
The penA_253 allele was identified in MenB isolates 
of the cc32 lineage in Europe in early 2012. The PubMLST 
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Figure 1. Neighbor-joining 
dendrogram (500 bootstrap 
values) for core genome 
sequences of clonal complex 
11 Neisseria meningitidis 
strains with serogroup 
W capsules, Western 
Australia, Australia, January 
2013–December 2016. The 
resistance phenotype for the 
penicillin G (PenG) gene for 
each isolate is provided using 
the following breakpoints: 
sensitive (MIC <0–0.06 mg/L), 
intermediate (0.12–0.25 mg/L) 
and resistant (>0.5 mg/L). 
Two clusters (A and B) were 
observed, which contain 
isolates that differ in penicillin 
resistance profile. Of 1,605 
core-genome loci, a minimum 
of 244 are different between 
clusters A and B. The more 
recent cluster B appeared 
in early 2016 and contains 
penicillin-resistant isolates. 
Strain ExNm672 does not 
belong to either cluster. The 
dendrogram is drawn to scale, 
and sum of branch lengths 
between 2 strains indicates 
the proportion of nucleotide 
differences between those 
core genomes (≈1.5 Mb) within the pairwise alignment. Gray shaded box indicates isolates in cluster B. Scale bar indicates nucleotide 
substitutions per site. ID, identification; ST, sequence type.
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database has 5 MenW:cc11 invasive isolates harboring this 
allele, all of which were obtained in Europe in 2016: 2 from 
France, 1 from Sweden, 1 from the United Kingdom, and 1 
from the Netherlands. Core-genome analysis showed clus-
tering of these isolates from Europe with cluster B isolates 
from Western Australia. (Figure 2).
To assess whether penA was responsible for the dif-
ference in penicillin resistance between the 2 clusters, 
the penA_253 allele from cluster B was transformed into 
all 8 penicillin-sensitive isolates in cluster A. We subse-
quently tested the penA_253 isogenic mutants obtained for 
penicillin resistance by using the Etest. All transformants 
displayed intermediate resistance to penicillin (4-fold in-
crease in MIC to 0.25 mg/L). These results indicate that the 
penA_253 allele plays a major role in increased resistance 
to penicillin among cluster B isolates.
However, exchange of penA did not fully account for 
the level of resistance displayed by drug-resistant clinical 
isolates. This finding suggests that acquisition of penicillin 
resistance among cluster B isolates is multifactorial. Be-
cause PBP1, PBP3, and PBP4 were identical in all isolates 
in clusters A and B, there must be additional as yet unde-
termined factors that play a role in conferring resistance to 
penicillin in cluster B isolates. A comparison of the core 
and accessory genomes of isolates in the 2 clusters is re-
quired to further elucidate this issue.
Conclusions
MenW is now the predominant serogroup causing IMD in 
Western Australia. Core-genome analysis identified a new 
cluster of penicillin-resistant MenW:cc11 clinical isolates 
that emerged throughout this region during early 2016. 
We demonstrated that the penA_253 allele has a major 
role in increasing penicillin resistance among isolates in 
this new cluster. Because penA_253 has been identified in 
MenW:cc11 isolates in Europe in 2016, jurisdictions are 
encouraged to monitor emergence of strains harboring this 
allele by PCR for culture-negative cases.
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Figure 2. Phylogenetic reconstruction by using an unrooted neighbor-net algorithm of core genomes of clonal complex 11 Neisseria 
meningitidis strains with serogroup W capsules (MenW:cc11), Western Australia, Australia, January 2013–December 2016. Blue circles 
indicate isolates in cluster A from Western Australia; red circles indicate isolates in cluster B from Western Australia; gray circle indicates 
ExNm672, a strain isolated from a traveler; open squares indicate the 5 MenW:cc11 isolates in the PubMLST database (http://pubmlst.
org/neisseria) that contains the penA_253 allele; and black squares indicate reference MenW:cc11 strains, isolated after 2010, as 
described by Lucidarme et al. (8). M7124 is the Hajj clone isolated in Saudi Arabia in 2000. Numbers in parentheses indicate PubMLST 
numbers of reference isolates. Scale bar indicates nucleotide substitutions per site.
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Rickettsia parkeri, a tickborne bacterium that causes a  
febrile, eschar-associated illness throughout many  
countries of the Western Hemisphere, is transmitted 
by Amblyomma ticks. In the United States, more than 
40 cases of R. parkeri rickettsiosis have been  
reported since its recognition in 2004. The Gulf Coast 
tick (Amblyomma maculatum) is the principal vector of R. parkeri 
in the United States, and all previously documented US infections 
arose within the known geographic range of these ticks.  
Confirmed cases of R. parkeri rickettsiosis also have been re-
ported from Uruguay and Argentina, where A. triste and  
A. tigrinum ticks serve as the principal vector species. Recent 
reviews of tick collection records and archived specimens 
documented and identified the presence of ticks very closely 
related to A. triste in several regions of the southwestern United 
States and adjacent regions of Mexico since at least 1942.
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